"Designing Growth Strategies is in our DNA"

Sickle Cell Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Treatment Modality [Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy {Hydroxyurea, and Branded Products (Endari, Adakveo, Oxbryta, Zynteglo, PYRUKYND (Mitapivat), CTX001, Inclacumab, MGTA-145, Vamifeport (VIT-2763), ALXN1820, FT-4202, and GBT021601)}], By End-user [Hospitals, Specialty Clinics, and Others], and Regional Forecast, 2023-2030

Last Updated: November 25, 2024 | Format: PDF | Report ID: FBI101009

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Get a Quote

man icon
Mail icon
Captcha refresh
  • 2019-2030
  • 2022
  • 2019-2021
  • 103






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X